Le Lézard
Classified in: Health
Subjects: PDT, FDA

Breckenridge Pharmaceutical, Inc. Announces Launch of Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien® CR)

BERLIN, Conn., July 8, 2021 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has launched Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien® CR), manufactured by Centaur Pharmaceuticals Pvt. Ltd.  Breckenridge will market the product in its own label and offer 6.25 mg and 12.5 mg strengths in bottles of 100. According to industry sales data, Ambien CR and its generics had annual sales of $42 million during the twelve months ending May 2021. The U.S. Food and Drug Administration previously granted final approval of this product's Abbreviated New Drug Application. 

About Breckenridge:
Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and quality of life of the patients we and our customers serve. 

About Centaur:
Centaur Pharmaceuticals is India's 32nd largest pharmaceutical company by prescriptions. Centaur provides end to end pharmaceutical solutions and is India's largest manufacturer and exporter of psychotropic API. Centaur exports its finished formulations to over 100 countries. Centaur recently introduced Woxheal, an NCE, for the first time in the world, in India for Diabetic Foot Ulcer. 

For further information, please contact: 
Breckenridge Pharmaceutical, Inc.
Robert Gasparino, Associate Vice President ? Business Development
Tel: 860-828-8140
E-mail: rgasparino@bpirx.com

*All brand names and trademarks are the property of their respective owners.  


SOURCE Breckenridge Pharmaceutical, Inc.

These press releases may also interest you

at 05:50
A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual...

at 05:30
The self-inflating bag market size is set to grow by USD 71.79 mn from 2020 to 2024, at a CAGR of 5% according to the latest market report by Technavio. ...

at 05:00
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced it has entered into a clinical trial collaboration agreement...

at 04:39
Redwood Pharma announces today a strategic move to accelerate development of RP501, the company's IntelliGel-based topical first-line therapy for dry eye disease. While RP101 remains a clinically tested and unique candidate drug for post-menopausal...

at 04:35
The global qPCR instruments market size is expected to reach USD 1.39 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. The market is driven by the introduction of...

at 04:30
The Olon Group announces the creation of an international network of scientific excellence to launch large-scale biocatalysis as an industrial technology used within its production facilities in Italy and around the world. The partnership, bringing...

News published on 8 july 2021 at 15:58 and distributed by: